This is an overarching subgroup that will cover the acute side effects/ toxicities that may arise as a consequence of any of the full spectrum of systemic anti-cancer therapy treatments, and work to provide support and guidance for the health care teams supporting patients.
The aims of the subgroup are:
- to work with the society members and relevant national groups and organisations to share information and highlight areas of best practice and areas of concern
- to collaborate with national groups and organisations to produce/review acute oncology guidelines and guidance
- to provide expert opinion relating to the management of treatment related toxicities to promote and support innovation and service development
- to review, develop and share information and guidance relating to acute effects of new and evolving treatments
The group will have key links with:
- National Immunotherapy Group
- The UK Chemotherapy Board
- UKONS Acute Oncology SACT Members Interest Group
The group will be led by:
|
Dr Ricky Dean Frazer
Consultant Medical Oncologist
Acute Oncology and Clinical
Lead for the South East Wales Immunotherapy Toxicity Service
and Acute Oncology Assessment Unit
Velindre Cancer Centre, Cardiff
|
Dr Anna Olsson-Brown Consultant in Medical Oncology Honorary Lecturer, University of Liverpool Immunotherapy Toxicity Lead, NIHR OTRC Clatterbridge Cancer Centre |
We wish to recruit a core group leadership team that is representative of our membership.
We are looking for an:
- Oncology Trainee
- Acute Oncology Nurse
- Oncology Pharmacist
who will work with our consultant leads to take this group forward.
Please contact philippajones@nhs.net if you wish to volunteer